Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions
- PMID: 27698858
- PMCID: PMC5038175
- DOI: 10.3892/ol.2016.5012
Differential expression of viral agents in lymphoma tissues of patients with ABC diffuse large B-cell lymphoma from high and low endemic infectious disease regions
Abstract
Diffuse large B-cell lymphoma (DLBCL), the most common type of non-Hodgkin's lymphoma (NHL) in adults, accounts for approximately 30-40% of newly diagnosed lymphomas worldwide. Environmental factors, such as viruses and bacteria, may contribute to cancer development through chronic inflammation and the integration of oncogenes, and have previously been indicated in cervical cancer, hepatocellular carcinoma, gastric cancer and lymphoproliferative disorders. In the present study, the presence of microbial agents was analyzed in the lymphoma tissue of patients with activated B-cell like (ABC) DLBCL. The present study compared two groups of patients from geographically varied regions that possess a difference in the prevalence of viral and other microbial agents. The patient populations were from Sweden (a low endemic infectious disease region) and Egypt (a high endemic infectious disease region). A differential expression of several viruses in lymphoma tissues was noted when comparing Swedish and Egyptian patients. JC polyomavirus (JCV) was detected in Swedish and Egyptian patients and, uniquely, the complete hepatitis B virus (HBV) genome was detected only in Egyptian lymphoma patients. None of these viruses were detected in control lymph tissues from Sweden or Egypt. In total, 38% of the Egyptian patients were found to have HBV surface antigens (HBsAgs) in their serum; however, HBsAgs were not found in any of the Swedish patients. The percentage of serum HBsAgs in Egyptian patients with ABC DLBCL was significantly increased compared with the general Egyptian population (P<0.05). The present study may support a notion that viral agents, including JCV and HBV, may be involved in the tumorigenesis of DLBCL in regions of high infectious disease.
Keywords: gene array; hepatitis B virus; lymphoma and Hodgkin disease; molecular genetics; virus.
Figures



Similar articles
-
Viral genomes and antigen detection of hepatitis B and C viruses in involved lymph nodes of Egyptian non-Hodgkin's lymphoma patients.Egypt J Immunol. 2006;13(1):105-14. Egypt J Immunol. 2006. PMID: 17974155
-
Expression of microRNA-1234 related signal transducer and activator of transcription 3 in patients with diffuse large B-cell lymphoma of activated B-cell like type from high and low infectious disease areas.Leuk Lymphoma. 2014 May;55(5):1158-65. doi: 10.3109/10428194.2013.824077. Epub 2013 Aug 31. Leuk Lymphoma. 2014. PMID: 23841503
-
Evaluation of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus seroprevalence in patients with diffuse large B cell lymphoma and Hodgkin's lymphoma.J Cancer Res Ther. 2021 Jul-Sep;17(4):951-955. doi: 10.4103/jcrt.JCRT_465_19. J Cancer Res Ther. 2021. PMID: 34528547
-
Hepatitis B Virus and B-cell lymphoma: evidence, unmet need, clinical impact, and opportunities.Front Oncol. 2023 Oct 20;13:1275800. doi: 10.3389/fonc.2023.1275800. eCollection 2023. Front Oncol. 2023. PMID: 37927464 Free PMC article. Review.
-
Rituximab: a review of its use in non-Hodgkin's lymphoma and chronic lymphocytic leukaemia.Drugs. 2003;63(8):803-43. doi: 10.2165/00003495-200363080-00005. Drugs. 2003. PMID: 12662126 Review.
Cited by
-
Viral Agents as Potential Drivers of Diffuse Large B-Cell Lymphoma Tumorigenesis.Viruses. 2022 Sep 22;14(10):2105. doi: 10.3390/v14102105. Viruses. 2022. PMID: 36298660 Free PMC article. Review.
-
Potential Pathogenic Impact of Cow's Milk Consumption and Bovine Milk-Derived Exosomal MicroRNAs in Diffuse Large B-Cell Lymphoma.Int J Mol Sci. 2023 Mar 23;24(7):6102. doi: 10.3390/ijms24076102. Int J Mol Sci. 2023. PMID: 37047075 Free PMC article. Review.
-
Associations of Viral Seroreactivity with AIDS-Related Non-Hodgkin Lymphoma.AIDS Res Hum Retroviruses. 2020 May;36(5):381-388. doi: 10.1089/AID.2019.0208. Epub 2020 Mar 2. AIDS Res Hum Retroviruses. 2020. PMID: 31789046 Free PMC article.
-
Seroprevalence of hepatitis B virus surface antigen (HBsAg) in Egypt (2000-2022): a systematic review with meta-analysis.BMC Infect Dis. 2023 Mar 10;23(1):151. doi: 10.1186/s12879-023-08110-5. BMC Infect Dis. 2023. PMID: 36899311 Free PMC article.
-
Axiom Microbiome Array, the next generation microarray for high-throughput pathogen and microbiome analysis.PLoS One. 2019 Feb 8;14(2):e0212045. doi: 10.1371/journal.pone.0212045. eCollection 2019. PLoS One. 2019. PMID: 30735540 Free PMC article.
References
-
- A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma, corp-author. The Non-Hodgkin's Lymphoma Classification Project. Blood. 1997;89:3909–3918. - PubMed
-
- Rosenwald A, Wright G, Chan WC, Connors JM, Campo E, Fisher RI, Gascoyne RD, Muller-Hermelink HK, Smeland EB, Giltnane JM, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med. 2002;346:1937–1947. doi: 10.1056/NEJMoa012914. - DOI - PubMed
-
- Liu YH, Xu FP, Zhuang HG, Lai KC, Xie D, Luo DL, Li L, Luo XL, Xu J, Zhang MH, et al. Clinicopathologic significance of immunophenotypic profiles related to germinal center and activation B-cell differentiation in diffuse large B-cell lymphoma from Chinese patients. Hum Pathol. 2008;39:875–884. doi: 10.1016/j.humpath.2007.10.013. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources